Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lieberman

Neurology

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Neurology|April 1, 1992
Dopamine agonists used as monotherapy in de novo PD patients: comparisons with selegilineA Lieberman
Neurology|April 1, 1992
Long-term experience with selegiline and levodopa in Parkinson's diseaseA Lieberman
Neurology|December 1, 1993
Combination therapy for PDA Lieberman
Neurology|June 20, 1998
Managing the neuropsychiatric symptoms of Parkinson's diseaseA Lieberman
Neurology|April 1, 1992
Emerging perspectives in Parkinson's diseaseA Lieberman
Neurology|October 1, 1975
Comparison of dopa decarboxylase inhibitor (carbidopa) combined with levodopa and levodopa alone on the cardiovascular system of patients with parkinson's diseaseM Leibowitz, A Lieberman
Neurology|April 1, 1992
The role of the regulatory enzymes of catecholamine synthesis in Parkinson's diseaseM Goldstein, A Lieberman
Neurology|July 1, 1997
Clinical evaluation of pramipexole in advanced Parkinson's disease: results of a double-blind, placebo-controlled, parallel-group studyA Lieberman, A Ranhosky, D Korts
Neurology|October 1, 1975
Comparison of dopa decarboxylase inhibitor (carbidopa) combined with levodopa and levodopa alone in Parkinson's diseaseA Lieberman, A Goodgold, S Jonas, et al.
Neurology|December 1, 1994
An algorithm for the management of Parkinson's diseaseW C Koller, D E Silver, A Lieberman
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Neurology|April 1, 1992
Dopamine agonists used as monotherapy in de novo PD patients: comparisons with selegilineA Lieberman
Neurology|April 1, 1992
Long-term experience with selegiline and levodopa in Parkinson's diseaseA Lieberman
Neurology|December 1, 1993
Combination therapy for PDA Lieberman
Neurology|June 20, 1998
Managing the neuropsychiatric symptoms of Parkinson's diseaseA Lieberman
Neurology|April 1, 1992
Emerging perspectives in Parkinson's diseaseA Lieberman
Neurology|October 1, 1975
Comparison of dopa decarboxylase inhibitor (carbidopa) combined with levodopa and levodopa alone on the cardiovascular system of patients with parkinson's diseaseM Leibowitz, A Lieberman
Neurology|April 1, 1992
The role of the regulatory enzymes of catecholamine synthesis in Parkinson's diseaseM Goldstein, A Lieberman
Neurology|July 1, 1997
Clinical evaluation of pramipexole in advanced Parkinson's disease: results of a double-blind, placebo-controlled, parallel-group studyA Lieberman, A Ranhosky, D Korts
Neurology|October 1, 1975
Comparison of dopa decarboxylase inhibitor (carbidopa) combined with levodopa and levodopa alone in Parkinson's diseaseA Lieberman, A Goodgold, S Jonas, et al.
Neurology|December 1, 1994
An algorithm for the management of Parkinson's diseaseW C Koller, D E Silver, A Lieberman
Pageof 3